Plain Votes

U.S. House · 119th Congress · H.R. 3546

Prescription Drug Price Relief Act of 2025

To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.

Follow

Log in to follow this bill and get an email when there’s a new vote (premium).

Sponsor
Ro KhannaD-CA-17
Introduced
May 21, 2025, in the House
Issue areas
Policy area
Health (from the Congressional Research Service)
Full text and actions
congress.gov

Votes on this bill (0)

Neither the House nor the Senate has held a roll-call vote on this bill.

Cosponsors (4)

4 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these

Original cosponsors

Signed on later